NSE filing, NSE: SOTAC. Summary written from the filing by ALFA Finder's alert engine.
Sotac Pharmaceuticals Limited: key numbers
- Share price
- ₹101.30
- Market cap
- ₹111.9 Cr
- Revenue (annual)
- ₹101.2 Cr
- Net profit (annual)
- ₹6.29 Cr
- P/E (TTM)
- 17.8×Sector 46.1×
- Promoter holding
- 72.85%
- FII holding
- 16.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sotac Pharmaceuticals Limited
All →Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals will hold an Extraordinary General Meeting on October 31, 2026, to seek shareholder approval for an increase in the company's authorised share capital.
Sotac Pharmaceuticals Capital Structure Change
Sotac Pharmaceuticals approved increasing its authorized share capital to Rs. 15 Crore. An Extra-Ordinary General Meeting will be convened to seek shareholder approval for this change.
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals Limited has announced a record date of September 23, 2026, for the payment of a final dividend of Rs. 0.20 per share.
Sotac Pharmaceuticals Annual General Meeting
Sotac Pharmaceuticals Limited issued the notice for its 11th Annual General Meeting on September 30, 2026. Ordinary and special business will be transacted.
Sotac Pharmaceuticals Bags ₹0.98 Cr Order
Sotac Pharmaceuticals received a purchase order from Intas Pharmaceuticals Limited for finished pharmaceutical formulations. The order is valued at ₹0.98 Crore.
- Value
- ₹0.98 Cr
- Execution
- September 05, 2026 to November 05, 2026
Sotac Pharmaceuticals Dividend
Sotac Pharmaceuticals recommended a final dividend of ₹0.20 per equity share for FY 2025-26. The distribution awaits shareholder approval at the upcoming AGM.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.